Cyprus vs Developing regions: Proportion of the target population … measles-containing-vaccine
Cyprus
97.0%
in 2024
Developing regions
75.0%
in 2024
Cyprus rank
22nd
Developing regions rank
23rd
Proportion of the target population … measles-containing-vaccine over time
- Cyprus
- Developing regions
How they compare
Cyprus currently reports 97.0% against 75.0% in Developing regions, a difference of 22.0%.
That makes Cyprus's figure about 1.3 times Developing regions's.
Across all 18 years both countries report, Cyprus has been ahead every year.
Cyprus ranks 22nd and Developing regions ranks 23rd of 195 countries.
Cyprus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cyprus | Developing regions | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.0% | 33.3% | 56.7% | Cyprus |
| 2010s | 88.0% | 56.0% | 32.0% | Cyprus |
| 2020s | 88.2% | 71.0% | 17.2% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Cyprus or Developing regions?
- Cyprus, at 97.0% against 75.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received between Cyprus and Developing regions?
- 22.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Developing regions?
- 18 years are reported by both, from 2007 to 2024.
- How do Cyprus and Developing regions rank globally for proportion of the target population who received?
- Cyprus ranks 22nd and Developing regions ranks 23rd of 195 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.